Queen's University (US) cancer researcher, Madhuri Koti, has discovered a biomarker that will help in predicting the success of chemotherapy in ovarian cancer. The discovery of biomarkers, which indicate a biological condition, could lead to better treatment options for ovarian cancer, the university said in a press release. Dr Koti conducted the study on more than 200 ovarian cancer patients.